Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis

The 1,3-beta-d-glucan (BDG) test is used for the diagnosis of invasive candidiasis (IC) in intensive care units (ICUs). However, its utility for patient management is unclear. This study assessed the impact of BDG test results on therapeutic decisions. This was a single-center observational study co...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Microbiol
Main Authors: Kritikos, Antonios, Poissy, Julien, Croxatto, Antony, Bochud, Pierre-Yves, Pagani, Jean-Luc, Lamoth, Frederic
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2020
Assuntos:
Mycology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7269378/
https://ncbi.nlm.nih.gov/pubmed/32238435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01996-19
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares